Overview

Repurposing Probenecid as a Positive Inotrope for the Treatment of Heart Failure

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
Probenecid is an FDA approved drug for the treatment gout and hyperuricemia. It has been used safely in humans for decades for this and other indications. The investigators have recently discovered that this drug can also stimulate other receptors in the heart and therefore improve its function. The hypothesis of this study is that probenecid can be used to improve the function of the heart and therefore the symptoms in patients with heart failure.
Phase:
Phase 2
Details
Lead Sponsor:
University of Cincinnati
Treatments:
Probenecid